CLOV vs NPCE
Clover Health Investments Corp (CLOV) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
CLOV currently screens at market cap $1.55B. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the CLOV and NPCE stock pages for the full models.
Not investment advice.